Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of Abbott Laboratories. A complete text table follows the diagram.
Diabetes care is now a $2.08 billion quarterly business inside a diversified healthcare portfolio spanning devices, diagnostics, nutrition and emerging-market medicines
Swipe to explore
Every segment revenue and consolidated financial flow is directly reported except net nonoperating income, which is the exact $104M arithmetic bridge from operating income to pretax income.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| Medical Devices | 1 | $5.5B | 49.6% of revenue |
| Diagnostic Products | 1 | $2.2B | Core lab, rapid and cancer diagnostics |
| Nutritional Products | 1 | $2.0B | Adult and pediatric nutrition |
| Established Pharmaceuticals | 1 | $1.4B | Emerging-market branded generics |
| Corporate revenue | 1 | $2M | Nonsegment activity |
| Net sales | 2 | $11.2B | Diversified healthcare platform |
| Operating earnings | 3 | $1.3B | 12.0% reported operating margin |
| Product & operating cost base | 3 | $9.8B | Manufacturing, people, R&D and amortization |
| Net nonoperating income | 3 | $104M | Investment, FX, interest and other items |
| Income before tax | 4 | $1.4B | 13.0% of revenue |
| Net earnings | 5 | $1.1B | $0.61 diluted EPS |
| Income tax | 5 | $372M | 25.7% effective rate |
| From | To | Value |
|---|---|---|
| Medical Devices | Net sales | $5.5B |
| Diagnostic Products | Net sales | $2.2B |
| Nutritional Products | Net sales | $2.0B |
| Established Pharmaceuticals | Net sales | $1.4B |
| Corporate revenue | Net sales | $2M |
| Net sales | Operating earnings | $1.3B |
| Net sales | Product & operating cost base | $9.8B |
| Operating earnings | Income before tax | $1.3B |
| Net nonoperating income | Income before tax | $104M |
| Income before tax | Net earnings | $1.1B |
| Income before tax | Income tax | $372M |